Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shin Yie Fong"'
Autor:
Wai Nam Liu, Wing Yan So, Sarah L. Harden, Shin Yie Fong, Melissa Xin Yu Wong, Wilson Wei Sheng Tan, Sue Yee Tan, Jessica Kai Lin Ong, Ravisankar Rajarethinam, Min Liu, Jia Ying Cheng, Lisda Suteja, Joe Poh Sheng Yeong, N. Gopalakrishna Iyer, Darren Wan-Teck Lim, Qingfeng Chen
Publikováno v:
Science Advances. 8
In recent decades, chimeric antigen receptor (CAR)–engineered immune effector cells have demonstrated promising antileukemic activity. Nevertheless, their efficacy remains unsatisfactory on solid cancers, plausibly due to the influence of tumor mic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95b7588e420152440dbcc9e56647fc23
https://doi.org/10.1126/sciadv.add1187
https://doi.org/10.1126/sciadv.add1187
Autor:
Seng Gee Lim, Yue Zhao, Wilson Wei Sheng Tan, Guan Huei Lee, Min Liu, Shin Yie Fong, Cheng Ean Chee, Sarah Harden, Timothy Shuen, Jia Ying Cheng, Yue Wan, Qingfeng Chen, Wai Nam Liu, Jerry Kok Yen Chan, Jiaxu Wang, Sue Yee Tan, Han Chong Toh
Publikováno v:
Hepatology. 74:1395-1410
BACKGROUND AND AIMS Recent development of multiple treatments for human hepatocellular carcinoma (HCC) has allowed for the selection of combination therapy to enhance the effectiveness of monotherapy. Optimal selection of therapies is based on both H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18dce5ad4fe73bdb84562f07d4b8e2c2
https://doi.org/10.1002/hep.31812
https://doi.org/10.1002/hep.31812
Autor:
Min Liu, Wilson Wei Sheng Tan, Wai Nam Liu, Qingfeng Chen, Narayanan Gopalakrishna Iyer, Darren Wan-Teck Lim, Sue Yee Tan, Shin Yie Fong
Publikováno v:
Cancer Research. 80:5060-5060
Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) is common in Southern China and South-East Asia. Immune checkpoint blockade (ICB) is being studied in NPC and initial monotherapy ICB studies show early promise. Currently, lack of re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f61597b1b2db4bf085fd9594da8ce43
https://doi.org/10.1158/1538-7445.am2020-5060
https://doi.org/10.1158/1538-7445.am2020-5060
Autor:
Edwin Kunxiang Huang, Wilson Wei Sheng Tan, Qingfeng Chen, Joe Poh Sheng Yeong, Lisda Suteja, Narayanan Gopalakrishna Iyer, Sherlly Lim, Wai Nam Liu, Darren Wan Teck Lim, Sue Yee Tan, Jerry Kok Yen Chan, Min Liu, Shin Yie Fong, Jia Ying Cheng
Publikováno v:
Cancers, Vol 12, Iss 1025, p 1025 (2020)
Cancers
Volume 12
Issue 4
Cancers
Volume 12
Issue 4
Immune checkpoint blockade (ICB) monotherapy shows early promise for the treatment of nasopharyngeal carcinoma (NPC) in patients. Nevertheless, limited representative NPC models hamper preclinical studies to evaluate the efficacy of novel ICB and com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c4a8e0ad05e9114d2616dc7e694dd62
https://doi.org/10.3390/cancers12041025
https://doi.org/10.3390/cancers12041025